HALBERT JON
SEC insider (Form 3/4/5 filer). CIK 0001189394. Director at Caris Life Sciences, Inc. (CAI). 5 reported Form 4/5 transactions since Sep 2024; latest on Aug 14, 2026. Located in IRVING, TX.
Companies HALBERT JON has filed insider reports for
- Caris Life Sciences, Inc. (CAI): Director
HALBERT JON
CIK: 0001189394
Transaction Breakdown
Open Market Buys (P)1 (20.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (60.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (20.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CAI
Caris Life Sciences, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Aug 14, 2026CAI
Caris Life Sciences, Inc.
AwardDirect13.2K shares- - May 15, 2026CAI
Caris Life Sciences, Inc.
PurchaseIndirect68K shares at avg. $14.56$990K - Feb 26, 2026CAI
Caris Life Sciences, Inc.
AwardDirect2.5K shares at avg. $20.06$50K - Jun 20, 2025CAI
Caris Life Sciences, Inc.
ConversionIndirect1.3M shares- - Feb 27, 2025CAI
Caris Life Sciences, Inc.
AwardDirect16.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 14, 2026 | CAI Caris Life Sciences, Inc. | Award | 13,192 | - | $0 | Direct |
| May 15, 2026 | CAI Caris Life Sciences, Inc. | Purchase | 68,000 | $14.56 | $990,080 | Indirect |
| Feb 26, 2026 | CAI Caris Life Sciences, Inc. | Award | 2,492 | $20.06 | $49,990 | Direct |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | Conversion | 1,250,000 | - | - | Indirect |
| Feb 27, 2025 | CAI Caris Life Sciences, Inc. | Award | 16,129 | - | - | Direct |
1-5 of 5 transactions